Anterix (ATEX) Operating Expenses (2016 - 2025)
Anterix filings provide 13 years of Operating Expenses readings, the most recent being $11.8 million for Q4 2025.
- On a quarterly basis, Operating Expenses fell 23.02% to $11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.7 million, a 17.59% decrease, with the full-year FY2025 number at $58.8 million, up 3.84% from a year prior.
- Operating Expenses hit $11.8 million in Q4 2025 for Anterix, down from $11.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $16.6 million in Q2 2024 to a low of $11.3 million in Q1 2021.
- Median Operating Expenses over the past 5 years was $13.9 million (2022), compared with a mean of $13.5 million.
- Biggest five-year swings in Operating Expenses: tumbled 30.35% in 2021 and later grew 16.6% in 2024.
- Anterix's Operating Expenses stood at $12.7 million in 2021, then increased by 16.34% to $14.8 million in 2022, then fell by 4.81% to $14.1 million in 2023, then increased by 8.67% to $15.3 million in 2024, then dropped by 23.02% to $11.8 million in 2025.
- The last three reported values for Operating Expenses were $11.8 million (Q4 2025), $11.9 million (Q3 2025), and $13.8 million (Q2 2025) per Business Quant data.